Several Wall Street analysts initiated coverage of Janus Living on Tuesday, issuing "Outperform" and "Buy" ratings. The real estate investment trust, which focuses on senior housing, began trading on the New York Stock Exchange on March 20 after being spun off from Healthpeak Properties.

Bank of America stated that Janus Living is well-positioned to benefit from demographic aging trends, noting that the first wave of baby boomers will turn 80 this year.

Analyst Farell Granat said in a report to clients, "We believe Janus Living's strategy focused on senior housing, its conservative balance sheet, and strong operator base will enable the company to deliver above-average earnings growth over time." His price target of $29 implies approximately 21% upside from Monday's closing price.

Morgan Stanley set a price target of $28 for the stock, suggesting 17% potential upside.

Analyst Ronald Kamdem noted in a report, "We see a compelling growth story supported by strong industry fundamentals. The near-term focus is on opportunities for strategic acquisitions and efficient scaling."

Meanwhile, JPMorgan pointed out that Janus Living is positioned at an opportune time and place. Analyst Michael Mueller stated that near-term internal growth should be three to four times the company's projected growth rate for the entire REIT sector.

He wrote, "External growth potential is equally substantial, as Janus begins post-IPO with a completely unlevered balance sheet and over $900 million in cash (excluding restricted cash) available for acquisitions. This combination offers a very unique positioning across the entire REIT space."

His price target of $26 implies 8% potential upside from Monday's closing price.